Par Pharmaceuticals

TIGAN

Manufacturer:

Par Pharmaceuticals

Tigan HCPCS:

J3250

HCPCS Code Descriptor:

Injection, trimethobenzamide hcl, up to 200 mg

Category:

J Code

Tigan NDCs:

42023-0119-25

Primary Type:

Oncology-Anti-Emetic

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intramuscular

Tigan CPT Codes:

Potential CPT administration codes for Tigan can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Tigan:

TIGAN is an Oncology-Anti-Emetic drug manufactured by Par Pharmaceuticals and administered via the Intramuscular route of administration. The J Code: J3250 is aligned to the drug TIGAN.

ACCESS PRICING AND MORE BY REGISTERING

J3250 Added Date:

January 1, 1982

J3250 Effective Date:

January 1, 1997

J3250 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Tigan billing and coding information.
Our team did not identify a source for Tigan patient assistance information. Please reach out to our team if you feel that this is a mistake.
TIGAN prescribing information can be found at the link below:
Information regarding TIGAN’s side effects can be found at MedlinePlus